Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc.

Patrussi L, Capitani N, Cannizzaro E, Finetti F, Lucherini OM, Pelicci PG, Baldari CT.

Cell Death Dis. 2014 Feb 20;5:e1068. doi: 10.1038/cddis.2014.44.

2.

Aberrant antibody affinity selection in SHIP-deficient B cells.

Leung WH, Tarasenko T, Biesova Z, Kole H, Walsh ER, Bolland S.

Eur J Immunol. 2013 Feb;43(2):371-81. doi: 10.1002/eji.201242809. Epub 2012 Dec 12.

3.

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.

Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, Slack FJ.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):E1695-704. doi: 10.1073/pnas.1201516109. Epub 2012 Jun 8.

4.

Insights into structure and function of SHIP2-SH2: homology modeling, docking, and molecular dynamics study.

Saqib U, Siddiqi MI.

J Chem Biol. 2011 Oct;4(4):149-58. doi: 10.1007/s12154-011-0057-7. Epub 2011 Feb 12.

5.

SH2-containing inositol 5'-phosphatase inhibits transformation of Abelson murine leukemia virus.

Fessler SP, Rosenberg N, Baughn LB.

J Virol. 2011 Sep;85(17):9239-42. doi: 10.1128/JVI.05115-11. Epub 2011 Jun 22.

6.

The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis.

Ramshaw HS, Guthridge MA, Stomski FC, Barry EF, Ooms L, Mitchell CA, Begley CG, Lopez AF.

Blood. 2007 Nov 15;110(10):3582-90. Epub 2007 Jul 16.

7.

Protein kinase C-delta is a negative regulator of antigen-induced mast cell degranulation.

Leitges M, Gimborn K, Elis W, Kalesnikoff J, Hughes MR, Krystal G, Huber M.

Mol Cell Biol. 2002 Jun;22(12):3970-80.

9.

p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction.

Suzu S, Tanaka-Douzono M, Nomaguchi K, Yamada M, Hayasawa H, Kimura F, Motoyoshi K.

EMBO J. 2000 Oct 2;19(19):5114-22.

10.
11.

Differential regulation of B cell development, activation, and death by the src homology 2 domain-containing 5' inositol phosphatase (SHIP).

Brauweiler A, Tamir I, Dal Porto J, Benschop RJ, Helgason CD, Humphries RK, Freed JH, Cambier JC.

J Exp Med. 2000 May 1;191(9):1545-54.

12.

Essential role for the C-terminal noncatalytic region of SHIP in FcgammaRIIB1-mediated inhibitory signaling.

Aman MJ, Walk SF, March ME, Su HP, Carver DJ, Ravichandran KS.

Mol Cell Biol. 2000 May;20(10):3576-89.

13.

A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: aberrant development and enhanced function of b lymphocytes in ship -/- mice.

Helgason CD, Kalberer CP, Damen JE, Chappel SM, Pineault N, Krystal G, Humphries RK.

J Exp Med. 2000 Mar 6;191(5):781-94.

14.

Altered responsiveness to chemokines due to targeted disruption of SHIP.

Kim CH, Hangoc G, Cooper S, Helgason CD, Yew S, Humphries RK, Krystal G, Broxmeyer HE.

J Clin Invest. 1999 Dec;104(12):1751-9.

15.

Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.

Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T.

J Exp Med. 1999 Apr 19;189(8):1229-42.

16.

SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival.

Liu Q, Sasaki T, Kozieradzki I, Wakeham A, Itie A, Dumont DJ, Penninger JM.

Genes Dev. 1999 Apr 1;13(7):786-91.

17.

Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells.

Huber M, Helgason CD, Scheid MP, Duronio V, Humphries RK, Krystal G.

EMBO J. 1998 Dec 15;17(24):7311-9.

18.
19.

The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling.

Liu Q, Oliveira-Dos-Santos AJ, Mariathasan S, Bouchard D, Jones J, Sarao R, Kozieradzki I, Ohashi PS, Penninger JM, Dumont DJ.

J Exp Med. 1998 Oct 5;188(7):1333-42.

20.

Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span.

Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F, Krystal G, Humphries RK.

Genes Dev. 1998 Jun 1;12(11):1610-20.

Supplemental Content

Support Center